October 24, 2007 – Researchers for the Radiation Therapy Oncology Group (RTOG) have found that emotional well-being is not an independent factor in predicting the survival time of patients with head and neck cancer.

The details of their research appear in the Dec. 1 issue of CANCER.

The investigators examined survival and quality of life data from two large RTOG multicenter clinical trials. Patients enrolled in the trials completed a baseline measure of quality of life that included an Emotional Well-Being subscale. The combined data set of approximately 1100 patients and 650 deaths allowed the researchers to make correlations between survival and emotional well-being, as well several other more predictive factors, on one of the largest pools of patients with uniformity of cancer site, treatment, quality of care, and quality of life reporting.

For more information: www.rtog.org


Additional Content

News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Lung Imaging

Oct. 20, 2026 — Optellum has announced that its Virtual Nodule Clinic (VNC) with Lung Cancer Prediction (LCP) AI is ...

Time October 21, 2026
arrow
News | ASTRO

Sept. 9, 2026 — The 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, will take place Sept. 26 to 30 ...

Time September 11, 2026
arrow
News | Prostate Cancer

Aug. 13, 2026 — Artera has announced the enrollment of the first patient in its DIRECT-AI registry study, marking the ...

Time August 14, 2026
arrow
News | Radiation Oncology

July 16, 2026 — Raidium has announced the U.S. launch of Raidium Read (R.Read), applying its AI-native imaging solution ...

Time July 16, 2026
arrow
Subscribe Now